Carolinas Wealth Consulting LLC cut its position in UnitedHealth Group Incorporated (NYSE:UNH)

Carolinas Wealth Consulting LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. . The fund owned 2,219 shares of the health care conglomerate’s stock after selling 135 shares during the quarter. Carolinas Wealth Consulting LLC’s holdings in UnitedHealth Group were worth $1,130,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have recently made changes to their positions in the business. Macroview Investment Management LLC raised its stake in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares of shares in the last quarter. Delos Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after buying an additional 53 shares in the last quarter. True Wealth Design LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $31,000. Bbjs Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the second quarter valued at about $31,000. Finally, Signature Resources Capital Management LLC boosted its stake in UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. 87.86% of the shares are currently held by hedge funds and other institutional investors.

UnitedHealth Group stock rose 0.4%

UNH opened at $580.32 on Thursday. The stock’s fifty-day moving average is $574.38, and its 200-day moving average is $519.42. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $607.94. The company has a market cap of $535.88 billion, a PE ratio of 35.47, a P/E/G ratio of 1.64 and a beta of 0.58. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88, and a current ratio of 0.88.

UnitedHealth Group (NYSE:UNH – Get Your Free Report ) last issued its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to analyst estimates of $98.73 billion. In the same quarter last year, the firm posted EPS of $6.14. The company’s revenue for the quarter was up 6.4% year-over-year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 27.69 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be paid a dividend of $2.10 per share. This represents a dividend of $8.40 on an annualized basis and a dividend yield of 1.45%. The ex-dividend date is Monday, September 16. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Insider activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The transaction was disclosed in a legal filing with the SEC, which is accessible via this hyperlink. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of UnitedHealth Group stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at approximately $16,812,029.88. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. 0.33% of shares are currently held by corporate insiders.

Changes in Analyst Ratings

UNH has been the subject of several recent research reports. Barclays boosted their target price on shares of UnitedHealth Group from $560.00 to $604.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Morgan Stanley upped their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Wells Fargo & Company upped their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Baird RW upgraded UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, TD Cowen boosted their price target on UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. One investment analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and a consensus price target of $614.17, based on data from MarketBeat.

Read our latest research report on UNH

UnitedHealth Group Company Profile

(Free report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight and Optum Rx. The UnitedHealthcare segment provides consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses and individuals; health care coverage and health and wellness services for people age 50 and older that address their needs; Medicaid plans, children’s health insurance and health care programs; and health and dental benefits and hospital and clinic services, and health care products and services for state care programs for the economically disadvantaged, medically underserved, and those without funded health care coverage by employer.

Featured stories

Want to see what other hedge funds own UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Get daily news and ratings for UnitedHealth Group – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for UnitedHealth Group and related companies with MarketBeat.com’s FREE daily email newsletter.